Bacterial cytological profiling identifies transmembrane anion transport as the mechanism of action for a urea-based antibiotic

References

• Blair JMA, Webber MA, Baylay AJ, et al. Molecular mechanisms of antibiotic resistance. Nat. Rev. Microbiol. 2015;13(1):42–51.
   PubMed Web of Science ®Google Scholar
• Nelson RE, Hatfield KM, Wolford H, et al. National Estimates of Healthcare Costs Associated With Multidrug-Resistant Bacterial Infections Among Hospitalized Patients in the United States. Clin. Infect. Dis. 2021;72(Suppl Supplement_1):S17–S26.
   PubMedGoogle Scholar
• Hudson MA, Lockless SW. Elucidating the Mechanisms of Action of Antimicrobial Agents. mBio. 2022;e02240–21.
   PubMed Web of Science ®Google Scholar
• Reygaert WC. An overview of the antimicrobial resistance mechanisms of bacteria. AIMS Microbiology. 2018;4(3):482.
   PubMed Web of Science ®Google Scholar
• Delcour AH. Outer membrane permeability and antibiotic resistance Biochime. Biophys. 2009;1794(5):808–816.
   Google Scholar
• Epand RM, Walker C, Epand RF, et al. Molecular mechanisms of membrane targeting antibiotics. Biochim Biophys Acta. 2016;1858(5):980–987.
   PubMed Web of Science ®Google Scholar
• Herschede SR, Gneid H, Dent T, et al. Bactericidal urea crown ethers target phosphatidylethanolamine membrane lipids. Org Biomol Chem. 2021;19(17):3838–3843.
   PubMed Web of Science ®Google Scholar
• Helgason E, Økstad OA, Caugant DA, et al. Bacillus anthracis, bacillus cereus, and bacillus thuringiensis—one species on the basis of genetic evidence. Appl Environ Microbiol. 2000;66(6):2627.
   PubMed Web of Science ®Google Scholar
• Duerr D, Hitz HR, Duennenberger M, et al., N-2-ethylhexyl-n’-aryl ureas as antibacterial agents. 1971. U.S. Patent No. 3,592,932.
   Google Scholar
• Balouiri M, Sadiki M, Ibnsouda SK. Methods for in vitro evaluating antimicrobial activity: a review. J Pharm Anal. 2016;6(2):71–79.
   PubMed Web of Science ®Google Scholar
• Nonejuie P, Burkart M, Pogliano K, et al. Bacterial cytological profiling rapidly identifies the cellular pathways targeted by antibacterial molecules. Proc Natl Acad Sci U S A. 2013;110(40):16169.
   PubMed Web of Science ®Google Scholar
• Levin PA, Angert ER. Small but mighty: cell size and bacteria. Cold Spring Harb Perspect Biol. 2015;7(7):a019216.
   PubMed Web of Science ®Google Scholar
• Lamsa A, Lopez-Garrido J, Quach D, et al. Rapid inhibition profiling in Bacillus subtilis to identify the mechanism of action of new antimicrobials. ACS Chem Biol. 2016;11(8):2222–2231.
   PubMed Web of Science ®Google Scholar
• Carpenter AE, Jones TR, Lamprecht MR, et al. CellProfiler: image analysis software for identifying and quantifying cell phenotypes. Genome Biol. 2006;7(10):1–11.
   Web of Science ®Google Scholar
• Schafer AB, Wenzel M. A how-to guide for mode of action analysis of antimicrobial peptides. Front Cell Infect Microbiol. 2020;10:540898.
   PubMed Web of Science ®Google Scholar
• Cushnie TP, O’Driscoll NH, Lamb AJ. Morphological and ultrastructural changes in bacterial cells as an indicator of antibacterial mechanism of action. Cell Mol Life Sci. 2016;73(23):4471–4492.
   PubMed Web of Science ®Google Scholar
• Sridhar S, Forrest S, Warne B, et al. High-content imaging to phenotype antimicrobial effects on individual bacteria at scale. mSystems. 2021;6(3):e00028–21.
   PubMed Web of Science ®Google Scholar
• Quach DT, Sakoulas G, Nizet V, et al. Bacterial cytological profiling (BCP) as a rapid and accurate antimicrobial susceptibility testing method for staphylococcus aureus. eBioMedicine. 2016;4:95–103
   PubMed Web of Science ®Google Scholar
• Roth BL, Poot M, Yue ST, et al. Bacterial viability and antibiotic susceptibility testing with SYTOX green nucleic acid stain. Appl Environ Microbiol. 1997;63(6):2421–2431.
   PubMed Web of Science ®Google Scholar
• Guyot J, Jeminet G, Prudhomme M, et al. Interaction of the calcium ionophore A.23187 (Calcimycin) with Bacillus cereus and Escherichia coli. Lett Appl Microbiol. 1993;16(4):192–195.
   Web of Science ®Google Scholar
• Nguyen LT, Haney EF, Vogel HJ. The expanding scope of antimicrobial peptide structures and their modes of action. Trends Biotechnol. 2011;29(9):464–472.
   PubMed Web of Science ®Google Scholar
• Williams ES, Gneid H, Marshall SR, et al. A supramolecular host for phosphatidylglycerol (PG) lipids with antibacterial activity. Org Biomol Chem. 2022;20(30):5958–5966.
   PubMed Web of Science ®Google Scholar
• Breukink E, van Heusden HE, Vollmerhaus PJ, et al. Lipid II is an intrinsic component of the pore induced by nisin in bacterial membranes. J Biol Chem. 2003;278(22):19898–19903.
   PubMed Web of Science ®Google Scholar
• Lamsa A, Liu W-T, Dorrestein PC, et al. The Bacillus subtilis cannibalism toxin SDP collapses the proton motive force and induces autolysis. Mol Microbiol. 2012;84(3):486–500.
   PubMed Web of Science ®Google Scholar
• Epand RF, Savage PB, Epand RM. Bacterial lipid composition and the antimicrobial efficacy of cationic steroid compounds (Ceragenins). Biochim. Biophys. Acta, Biomembr. 2007;1768(10):2500–2509.
   Web of Science ®Google Scholar
• Andrews NJ, Haynes CJE, Light ME, et al. Structurally simple lipid bilayer transport agents for chloride and bicarbonate. Chem Sci. 2011;2(2):256–260.
   Web of Science ®Google Scholar
• Moore SJ, Wenzel M, Light ME, et al. Towards “drug-like” indole-based transmembrane anion transporters. Chem Sci. 2012;3(8):2501–2509.
   Web of Science ®Google Scholar
• Seganish JL, Davis JT. Prodigiosin is a chloride carrier that can function as an anion exchanger. Chem Commun. 2005;46:5781–5783.
   PubMed Web of Science ®Google Scholar
• Rastogi S, Marchal E, Uddin I, et al. Synthetic prodigiosenes and the influence of C-ring substitution on DNA cleavage, transmembrane chloride transport and basicity. Org Biomol Chem. 2013;11(23):3834–3845.
   PubMed Web of Science ®Google Scholar
• Sato T, Konno H, Tanaka Y, et al. Prodigiosins as a New Group of H+/Cl−Symporters That Uncouple Proton Translocators. J Biol Chem. 1998;273(34):21455–21462.
   PubMed Web of Science ®Google Scholar
• Melvin MS, Tomlinson JT, Saluta GR, et al. Double-Strand DNA Cleavage by Copper·Prodigiosin. J Am Chem Soc. 2000;122(26):6333–6334.
   Web of Science ®Google Scholar
• Kimyon Ö, Das T, Ibugo AI, et al. Serratia secondary metabolite prodigiosin inhibits pseudomonas aeruginosa biofilm development by producing reactive oxygen species that damage biological molecules. Front Microbiol. 2016;7:972.
   PubMed Web of Science ®Google Scholar
• Lin S-R, Chen Y-H, Tseng F-J, et al. The production and bioactivity of prodigiosin: quo vadis? Drug Discov Today. 2020;25(5):828–836.
   PubMed Web of Science ®Google Scholar
• Choi SY, Lim S, K-h Y, et al. Biotechnological Activities and Applications of Bacterial Pigments Violacein and Prodigiosin. J Biol Eng. 2021;15(1):10.
   PubMed Web of Science ®Google Scholar
• Wu X, Judd LW, HoweENW, et al. Nonprotonophoric Electrogenic Cl− Transport Mediated by Valinomycin-like Carriers. Chem. 2016;1(1):127–146.
   Web of Science ®Google Scholar
• Wu X, Howe ENW, Gale PA. Supramolecular Transmembrane Anion Transport: new Assays and Insights. Acc Chem Res. 2018;51(8):1870–1879.
   PubMed Web of Science ®Google Scholar
• Pinkerton M, Steinrauf L, Dawkins P. The molecular structure and some transport properties of valinomycin. Biochem Biophys Res Commun. 1969;35(4):512–518.
   PubMed Web of Science ®Google Scholar
• Łowicki D, Huczyński A. Structure and Antimicrobial Properties of Monensin A and Its Derivatives: summary of the Achievements. Biomed Res Int. 2013;2013:742149.
   PubMed Web of Science ®Google Scholar
• Share AI, Patel K, Nativi C, et al. Chloride anion transporters inhibit growth of methicillin-resistant Staphylococcus aureus (MRSA) in vitro. Chem Commun. 2016;52(48):7560–7563.
   PubMed Web of Science ®Google Scholar
• Elie C-R, Hébert A, Charbonneau M, et al. Benzimidazolium-based synthetic chloride and calcium transporters in bacterial membranes. Org Biomol Chem. 2013;11(6):923–928.
   PubMed Web of Science ®Google Scholar
• Elie CR, David G, Schmitzer AR. Strong Antibacterial Properties of Anion Transporters: a Result of Depolarization and Weakening of the Bacterial Membrane. J Med Chem. 2015;58(5):2358–2366.
   PubMed Web of Science ®Google Scholar
• Gravel J, Schmitzer AR. Imidazolium and benzimidazolium-containing compounds: from simple toxic salts to highly bioactive drugs. Org Biomol Chem. 2017;15(5):1051–1071.
   PubMed Web of Science ®Google Scholar
• Carreira-Barral I, Rumbo C, Mielczarek M, et al. Small molecule anion transporters display in vitro antimicrobial activity against clinically relevant bacterial strains. Chem Commun. 2019;55(68):10080–10083.
   PubMed Web of Science ®Google Scholar
• Benarroch JM, Asally M. The Microbiologist’s Guide to Membrane Potential Dynamics. Trends Microbiol. 2020;28(4):304–314.
   PubMed Web of Science ®Google Scholar
• Matsuzaki K. Control of cell selectivity of antimicrobial peptides. Biochim. Biophys. Acta, Biomembr. 2009;1788(8):1687–1692.
   PubMed Web of Science ®Google Scholar
• Oddo A, Hansen PR. Hemolytic Activity of Antimicrobial Peptides. In: Hansen PR, editor. Antimicrobial Peptides: methods and Protocols. New York: Springer New York; 2017. p. 427–435.
   Google Scholar